Our analysis failed to detect notable toxicity associated with body or organ weight, blood populations, goblet cell metaplasia, or other gastrointestinal toxicity such as the one previously demonstrated for gamma secretase inhibitor drugs used to block NOTCH1 activity in T-ALL therapy (fig. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.